82 related articles for article (PubMed ID: 8005568)
1. Prolactin (PRL) response to oral or vaginal bromoergocriptine in hyperprolactinemic women.
Dash RJ; Ajmani AK; Sialy R
Horm Metab Res; 1994 Mar; 26(3):164. PubMed ID: 8005568
[No Abstract] [Full Text] [Related]
2. Effectiveness of vaginal bromocriptine in treating women with hyperprolactinemia.
Kletzky OA; Vermesh M
Fertil Steril; 1989 Feb; 51(2):269-72. PubMed ID: 2912773
[TBL] [Abstract][Full Text] [Related]
3. Vaginal bromocriptine: pharmacology and effect on serum prolactin in normal women.
Vermesh M; Fossum GT; Kletzky OA
Obstet Gynecol; 1988 Nov; 72(5):693-8. PubMed ID: 3173919
[TBL] [Abstract][Full Text] [Related]
4. Vaginal bromocriptine--clinical and biochemical effects.
Ginsburg J; Hardiman P; Thomas M
Gynecol Endocrinol; 1992 Jun; 6(2):119-26. PubMed ID: 1502929
[TBL] [Abstract][Full Text] [Related]
5. Clinical and hormonal response to short-term intermittent versus continuous oral bromocriptine in hyperprolactinemic women.
Parra A; Crespo G; Coria I; Espinosa de los Monteros A
Int J Fertil Menopausal Stud; 1995; 40(2):96-101. PubMed ID: 7599666
[TBL] [Abstract][Full Text] [Related]
6. Vaginal bromocriptine in hyperprolactinemic patients and puerperal women.
Jasonni VM; Raffelli R; de March A; Frank G; Flamigni C
Acta Obstet Gynecol Scand; 1991; 70(6):493-5. PubMed ID: 1763616
[TBL] [Abstract][Full Text] [Related]
7. A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.
Gianola D; Pedroncelli A; Montini M; Tengattini F; Pagani MD; Cortesi L; Cappi MP; Gherardi F; Lancranjan I; Pagani G
Gynecol Endocrinol; 1991 Sep; 5(3):213-6. PubMed ID: 1776507
[TBL] [Abstract][Full Text] [Related]
8. Superiority of newly developed vaginal suppositories over vaginal use of commercial bromocriptine tablets: a randomized controlled clinical trial.
Darwish AM; Farah E; Gadallah WA; Mohammad II
Reprod Sci; 2007 Apr; 14(3):280-5. PubMed ID: 17636242
[TBL] [Abstract][Full Text] [Related]
9. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
Fukunaga T
Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
[TBL] [Abstract][Full Text] [Related]
10. Long-acting oral bromocriptine (Parlodel SRO) in the treatment of hyperprolactinemia.
Weingrill CO; Mussio W; Moraes CR; Portes E; Castro RC; Lengyel AM
Fertil Steril; 1992 Feb; 57(2):331-5. PubMed ID: 1735484
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy in hyperprolactinemic infertile women treated with vaginal bromocriptine: report of two cases and review of the literature.
Ricci G; Giolo E; Nucera G; Pozzobon C; De Seta F; Guaschino S
Gynecol Obstet Invest; 2001; 51(4):266-70. PubMed ID: 11408739
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia.
Darwish AM; El-Sayed AM; El-Harras SA; Khaled KA; Ismail MA
Fertil Steril; 2008 Nov; 90(5):1864-8. PubMed ID: 18462734
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating levels of bromocriptine after vaginal compared with oral administration.
Katz E; Weiss BE; Hassell A; Schran HF; Adashi EY
Fertil Steril; 1991 May; 55(5):882-4. PubMed ID: 2022266
[TBL] [Abstract][Full Text] [Related]
14. Vaginal bromocriptine administration in patients with hyperprolactinemia.
Carranza-Lira S; González-Sánchez JL; Martínez-Chequer JC
Int J Gynaecol Obstet; 1999 Apr; 65(1):77-8. PubMed ID: 10390107
[No Abstract] [Full Text] [Related]
15. Medical management of hyperprolactinemia: a lower dose of bromocriptine may be effective.
Soto-Albors CE; Randolph JF; Ying YK; Riddick DH
Fertil Steril; 1987 Aug; 48(2):213-7. PubMed ID: 3609332
[TBL] [Abstract][Full Text] [Related]
16. Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy study.
Moro M; Maraschini C; Toja P; Masala A; Alagna S; Rovasio PP; Ginanni A; Lancranjan I; Cavagnini F
Horm Res; 1991; 35(3-4):137-41. PubMed ID: 1806467
[TBL] [Abstract][Full Text] [Related]
17. Domperidone antagonizes bromoergocriptine--induced nausea and vomiting without affecting its inhibition of prolactin secretion in puerperal women.
Nappi C; Colace G; Di Renzo GF; Taglialatela M; Amoroso S; Annunziato L; Montemagno U
Eur J Clin Pharmacol; 1987; 32(5):457-60. PubMed ID: 3622595
[TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinemia in oligospermic Nigerian males: effect of bromocriptine treatment.
Modebe O
Int J Fertil Menopausal Stud; 1994; 39(2):95-9. PubMed ID: 8012447
[TBL] [Abstract][Full Text] [Related]
19. [Using bromocriptine vaginally for the treatment of hyperprolactinemia].
Hafidi A; Gharbi MH; Kadiri A
Contracept Fertil Sex; 1996 Jan; 24(1):11-4. PubMed ID: 8932749
[No Abstract] [Full Text] [Related]
20. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study.
Verhelst JA; Froud AL; Touzel R; Wass JA; Besser GM; Grossman AB
Acta Endocrinol (Copenh); 1991 Oct; 125(4):385-91. PubMed ID: 1683503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
